Cryptoporus volvatus Extract Inhibits Influenza Virus Replication In Vitro and In Vivo
Open Access
- 1 December 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (12), e113604
- https://doi.org/10.1371/journal.pone.0113604
Abstract
Influenza virus is the cause of significant morbidity and mortality, posing a serious health threat worldwide. Here, we evaluated the antiviral activities of Cryptoporus volvatus extract on influenza virus infection. Our results demonstrated that the Cryptoporus volvatus extract inhibited different influenza virus strain replication in MDCK cells. Time course analysis indicated that the extract exerted its inhibition at earlier and late stages in the replication cycle of influenza virus. Subsequently, we confirmed that the extract suppressed virus internalization into and released from cells. Moreover, the extract significantly reduced H1N1/09 influenza virus load in lungs and dramatically decreased lung lesions in mice. And most importantly, the extract protected mice from lethal challenge with H1N1/09 influenza virus. Our results suggest that the Cryptoporus volvatus extract could be a potential candidate for the development of a new anti-influenza virus therapy.Keywords
This publication has 34 references indexed in Scilit:
- Cryptoporus volvatus Extract Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) In Vitro and In VivoPLOS ONE, 2013
- Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?Clinical Microbiology Reviews, 2012
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 InfluenzaAnnals of Internal Medicine, 2011
- Characterization of an Artificial Swine-Origin Influenza Virus with the Same Gene Combination as H1N1/2009 Virus: A Genesis Clue of Pandemic StrainPLOS ONE, 2011
- Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health districtVaccine, 2011
- Receptor Tyrosine Kinase Inhibitors Block Multiple Steps of Influenza A Virus ReplicationJournal of Virology, 2011
- Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase InhibitorsThe Journal of Infectious Diseases, 2011
- Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 HoursEmerging Infectious Diseases, 2010
- Natural products in drug discoveryDrug Discovery Today, 2008
- Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1Letters in Applied Microbiology, 2007